Quest Diagnostics Incorporated (DGX) Insider Trading Activity

Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.

Show less

Over the last 12 months, insiders at Quest Diagnostics Incorporated have bought $0 and sold $37.82M worth of Quest Diagnostics Incorporated stock.

On average, over the past 5 years, insiders at Quest Diagnostics Incorporated have bought $0 and sold $25.14M worth of stock each year.

There was no buying activity among insiders over the last 12 months.

The last purchase of 8,000 shares for transaction amount of $444,046 was made by GUINAN MARK (Senior Vice President & CFO) on 2014‑05‑05.